198 related articles for article (PubMed ID: 19290019)
1. Definitive radiotherapy with adjuvant long-term antiandrogen treatment for locally advanced prostate cancer: health-related quality of life and hormonal changes.
Berg A; Dahl AA; Bruland ØS; Bjøro T; Aanensen MS; Fosså SD
Prostate Cancer Prostatic Dis; 2009; 12(3):269-76. PubMed ID: 19290019
[TBL] [Abstract][Full Text] [Related]
2. Impact of hormonal therapy prior to radical prostatectomy on the recovery of quality of life.
Namiki S; Saito S; Tochigi T; Kuwahara M; Ioritani N; Yoshimura K; Terai A; Koinuma N; Arai Y
Int J Urol; 2005 Feb; 12(2):173-81. PubMed ID: 15733112
[TBL] [Abstract][Full Text] [Related]
3. Insurance and quality of life in men with prostate cancer: data from the Cancer of the Prostate Strategic Urological Research Endeavor.
Sadetsky N; Lubeck DP; Pasta DJ; Latini DM; DuChane J; Carroll PR
BJU Int; 2008 Mar; 101(6):691-7. PubMed ID: 18291018
[TBL] [Abstract][Full Text] [Related]
4. [Study of sexual hormone changes in prostate cancer patients before and after androgen deprivation therapy].
Ying J; Yao DH; Ren XM
Zhonghua Nan Ke Xue; 2003 Jun; 9(3):191-2, 196. PubMed ID: 12861832
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant hormonal therapy impairs sexual outcome among younger men who undergo external beam radiotherapy for localized prostate cancer.
Hollenbeck BK; Wei JT; Sanda MG; Dunn RL; Sandler HM
Urology; 2004 May; 63(5):946-50. PubMed ID: 15134986
[TBL] [Abstract][Full Text] [Related]
6. Androgen deprivation therapy for prostate cancer: effects on hand function.
Soyupek F; Soyupek S; Perk H; Ozorak A
Urol Oncol; 2008; 26(2):141-6. PubMed ID: 18312932
[TBL] [Abstract][Full Text] [Related]
7. Reduction of irradiation volume and toxicities with 3-D radiotherapy planning over conventional radiotherapy for prostate cancer treated with long-term hormonal therapy.
Yamazaki H; Nishiyama K; Tanaka E; Maeda O; Meguro N; Kinouchi T; Usami M; Kakimoto K; Ono Y; Nishimura T
Anticancer Res; 2008; 28(6B):3913-20. PubMed ID: 19192649
[TBL] [Abstract][Full Text] [Related]
8. Use of the Charlson combined comorbidity index to predict postradiotherapy quality of life for prostate cancer patients.
Wahlgren T; Levitt S; Kowalski J; Nilsson S; Brandberg Y
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):997-1004. PubMed ID: 20932681
[TBL] [Abstract][Full Text] [Related]
9. Coping and health-related quality of life in men with prostate cancer randomly assigned to hormonal medication or close monitoring.
Green HJ; Pakenham KI; Headley BC; Gardiner RA
Psychooncology; 2002; 11(5):401-14. PubMed ID: 12228873
[TBL] [Abstract][Full Text] [Related]
10. Changes in continence and health-related quality of life after curative treatment and watchful waiting of prostate cancer.
Katz G; Rodriguez R
Urology; 2007 Jun; 69(6):1157-60. PubMed ID: 17572206
[TBL] [Abstract][Full Text] [Related]
11. Promising long-term health-related quality of life after high-dose-rate brachytherapy boost for localized prostate cancer.
Wahlgren T; Nilsson S; Lennernäs B; Brandberg Y
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):662-70. PubMed ID: 17499452
[TBL] [Abstract][Full Text] [Related]
12. Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that relapsed after initial maximum androgen blockade.
Suzuki H; Okihara K; Miyake H; Fujisawa M; Miyoshi S; Matsumoto T; Fujii M; Takihana Y; Usui T; Matsuda T; Ozono S; Kumon H; Ichikawa T; Miki T;
J Urol; 2008 Sep; 180(3):921-7. PubMed ID: 18635218
[TBL] [Abstract][Full Text] [Related]
13. Effect of androgen deprivation therapy on quality of life in Japanese men with prostate cancer.
Kato T; Komiya A; Suzuki H; Imamoto T; Ueda T; Ichikawa T
Int J Urol; 2007 May; 14(5):416-21. PubMed ID: 17511724
[TBL] [Abstract][Full Text] [Related]
14. Prospective evaluation of quality of life in prostate cancer patients receiving combined treatment of postoperative radiotherapy plus androgen suppression for PT3 or positive resection margin after radical prostatectomy.
Choo R; Pearce A; Danjoux C; Morton G; Deboer G; Szumacher E; Loblaw A; Cheung P
Eur Urol; 2007 Dec; 52(6):1645-50. PubMed ID: 17140722
[TBL] [Abstract][Full Text] [Related]
15. Impact of androgen deprivation therapy on physical and cognitive function, as well as quality of life of patients with nonmetastatic prostate cancer.
Joly F; Alibhai SM; Galica J; Park A; Yi QL; Wagner L; Tannock IF
J Urol; 2006 Dec; 176(6 Pt 1):2443-7. PubMed ID: 17085125
[TBL] [Abstract][Full Text] [Related]
16. Five-year follow-up of health-related quality of life after intensity-modulated radiation therapy for prostate cancer.
Namiki S; Ishidoya S; Ito A; Tochigi T; Numata I; Narazaki K; Yamada S; Takai Y; Arai Y
Jpn J Clin Oncol; 2009 Nov; 39(11):732-8. PubMed ID: 19666904
[TBL] [Abstract][Full Text] [Related]
17. Measuring patients' expectations regarding health-related quality-of-life outcomes associated with prostate cancer surgery or radiotherapy.
Symon Z; Daignault S; Symon R; Dunn RL; Sanda MG; Sandler HM
Urology; 2006 Dec; 68(6):1224-9. PubMed ID: 17141840
[TBL] [Abstract][Full Text] [Related]
18. Health-related quality of life after adjuvant and salvage postoperative radiotherapy for prostate cancer - a prospective analysis.
Pinkawa M; Fischedick K; Asadpour B; Gagel B; Piroth MD; Holy R; Krenkel B; Eble MJ
Radiother Oncol; 2008 Jul; 88(1):135-9. PubMed ID: 18022263
[TBL] [Abstract][Full Text] [Related]
19. Partnership and outcomes in men with prostate cancer.
Bergman J; Gore JL; Saigal CS; Kwan L; Litwin MS
Cancer; 2009 Oct; 115(20):4688-94. PubMed ID: 19626653
[TBL] [Abstract][Full Text] [Related]
20. [Interest of the radiotherapy-hormonotherapy association in the treatment of the high-risk prostate cancer].
Bolla M; Fourneret P; Descotes JL
Bull Cancer; 2008 Dec; 95(12):1213-8. PubMed ID: 19091656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
